Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.

GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with ...

Many modern drugs are based on antibodies. These proteins very specifically identify a certain structure on the surface of ...

Cells are in constant competition with each other and so eliminate diseased or unwanted cells. Cell competition is therefore a central principle for maintaining the health of tissues and organs.

Xintela's interim analysis of data from the knee osteoarthritis clinical study shows safety and positive efficacy results, 18 months after treatment with XSTEM. The results demonstrate statistically s ...

Our immune system is constantly working to protect us from infections and injuries. One of its most powerful tools is ...

In a recent essay, scientists challenge the prevailing genetic-focused model of cancer, advocating for a shift towards more ...

The profoundly ‘atomic’ character of the universe is visible in everyday experience:in raindrops and grains of sand, in the hosts of the living.”Pierre ...

Artificial Intelligence (AI) has revolutionized countless industries, and healthcare is no exception. Among the most ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers at UZH have now ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Exelixis, Inc.

Monks, the global, purely digital, data-driven, unitary operating brand of S4 Capital plc, today announced its collaboration with NVIDIA to launch an Agentic AI Advisory Group and the Monks Foundry, ...